Secondaries

The Gulf-based institution retained its target allocation of 12-17% and has capitalised on the growth of secondaries.

Why GPs should stop worrying and learn to love defence. Plus: Future Fund's CIO is heading to the Middle East; and investors are increasingly hungry for small-cap CVs. Here's today's brief, for our valued subscribers only.

Unlike more traditional continuation fund deals, no assets or fund stakes are being rolled into a new vehicle in this deal.

LPs share their investment priorities for a changing world. Plus: how institutional heavyweights are approaching impact in 2025; and New Jersey Division of Investment mulls a secondaries sale. Here's today's brief, for our valued subscribers only.

The pension joins several large North American LPs that have considered or already sold more than $1bn of private markets exposure this year.

A key concern is that a GP may not have market-tested the highest selling price of an asset, according to the $212bn pension's senior investment officer for PE.

Apogem Capital, an investor in more than 60 GP-led secondaries, and law firm Willkie Farr & Gallagher team up to explain how lead investors and legal counsel can help investors in continuation funds feel comfortable that the sponsor is aligned with their interests.

The semi-liquid fund aims to provide 'diversified access to high-quality private growth companies' through directs and secondaries.

CVC has disclosed the expected launch date of its next private equity behemoth. Plus: Japanese pensions pile into alts; and a flurry of senior people moves in Asia. Here's today's brief, for our valued subscribers only.